Clinical proteomics has only become possible because of recent advances in mass spectrometry, protein and peptide separation methods and informatics. These capabilities now fuel the discovery and identification of new biomarkers to aid in diagnosis of disease, prediction of clinical outcome, and the monitoring of therapy.
Most of our research has a clinical focus and some current areas of interest include:
- The impact of the environment on health and disease
- Cystic fibrosis and disorders of the lung, including asthma
- The chemistry of the human tear film
- Down's syndrome and disorders of the central nervous system
- Lung, breast, prostate and thyroid cancer
- Infectious diseases
- Endocrine disorders
